Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review.
Sign Up to like & getrecommendations! Published in 2022 at "Life sciences"
DOI: 10.1016/j.lfs.2022.120543
Abstract: Metabolic diseases, such as diabetes, gout and hyperlipidemia are global health challenges. Among them, diabetes has been extensively investigated. Type 2 diabetes mellitus (T2DM), which is characterized by hyperglycemia, is a complex metabolic disease that… read more here.
Keywords: inhibitors improve; metabolic diseases; molecular mechanisms; mechanisms sglt2 ... See more keywords
In advanced progressive CKD, discontinuing RAS inhibitors did not improve eGFR at 3 y
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Internal Medicine"
DOI: 10.7326/j23-0001
Abstract: SOURCE CITATION Bhandari S, Mehta S, Khwaja A, et al. Renin-angiotensin system inhibition in advanced chronic kidney disease. N Engl J Med. 2022;387:2021-32. 36326117. read more here.
Keywords: advanced progressive; ras inhibitors; inhibitors improve; discontinuing ras ... See more keywords